Product Code: PM2253
The global anatomic pathology market size is expected to reach USD 65.54 billion by 2030, according to a new study by Polaris Market Research. The report "Anatomic Pathology Market Share, Size, Trends, Industry Analysis Report, By Product; By Application (Disease Diagnosis, Drug Discovery and Development, Others); By End-Use (Hospitals, Research Laboratories, Diagnostic Laboratories, Others), By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global industry is expected to increase rapidly due to the growing focus on customized care and a large number of supporting programs and training modules provided by the government. The geriatric population is rapidly growing, as is the incidence rate of cancer and other chronic disorders. The industry is being driven by an increase in chronic disease cases and a need to address the quick diagnosis of medical disorders. Modern anatomic pathology technology is becoming more widely used because of the significant rise in cancer cases.
The industry is being driven by an increase in chronic disease cases and a need to address the quick diagnosis of medical disorders. Because the elderly are more susceptible to numerous illnesses, this demographic trend is expected to significantly increase the prevalence of several chronic diseases, including cancer, worldwide.
Furthermore, rising awareness and increased patient pool in developing countries propel the industry forward. Additionally, the industry is being driven by an increase in healthcare expenditure and the use of biomarkers during illness diagnosis.
Over the projected period, the drug discovery and development segment is expected to increase at a profitable rate. During preclinical studies, pathologists' tissue analysis provides pharmaceutical companies with a wide range of information. Moreover, the biologic's manufacturing service is also expected to register significant growth in the overall industry. This is due to the robust pipeline of new biological drugs due to the growing commercial success of biopharma companies across developed and developing economies paving the segment's growth.
Agilent Technologies, Abcam plc, Amos Scientific Pty Ltd., Bio SB, BioGenex, Bright Instruments, Cell Signaling Technology, Inc., Beckton, CellPath Ltd., Danaher Corporation, Diapath S.p.A, Dickson and Company, Cardinal Health, F. Hoffmann-La Roche AG, Hologic, Inc., Jinhua Yidi Medical Equipment Co., Ltd., Histo-Line Laboratories, Laboratory Corporation of America Holdings, Lupetec, Medimeas, Merck KGaA, MICROS AUSTRIA, Milestone Medical, NeoGenomics Laboratories, Inc., MEDITE Medical GmbH, Quest Diagnostics Incorporated, R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED, PHC Holdings Corporation, Sakura Finetek, and SLEE medical GmbH are some of the major players in the market.
In December 2021, Quest Diagnostics Incorporated introduced the liquid biopsy-based Target Selector NGS Lung Panel test. In October 2021, Roche partnered with PathAI, a global leader in artificial intelligence (AI)-based technologies. The firms will collaborate on pathologists' embedded image analysis workflow as part of the development and distribution arrangement.
Polaris Market Research has segmented the anatomic pathology market report based on product, application, end-use, and region:
Anatomic Pathology, Product Outlook (Revenue - USD Billion, 2018 - 2030)
Instruments
Microtomes & Cryostat
Tissue Processors
Automatic Stainers
Whole Slide Imaging (WSI) Scanners
Other Products
Consumables
Reagents & Antibodies
Probes & Kits
Others
Services
Anatomic Pathology, Application Outlook (Revenue - USD Billion, 2018 - 2030)
Disease Diagnosis
Drug Discovery and Development
Others
Anatomic Pathology, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Hospitals
Research Laboratories
Diagnostic Laboratories
Others
Anatomic Pathology, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
Italy
France
Spain
Austria
Netherlands
Asia Pacific
China
Japan
India
Indonesia
Malaysia
South Korea
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Israel
Saudi Arabia
South Africa
UAE
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Anatomic Pathology Market Insights
- 4.1. Anatomic Pathology - Industry Snapshot
- 4.2. Anatomic Pathology Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.2. Restraints and Challenges
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Anatomic Pathology Market Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Anatomic Pathology Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 5.3. Instruments
- 5.3.1. Global Anatomic Pathology Market, by Instruments, by Region, 2018 - 2030 (USD Billion)
- 5.3.2. Microtomes & Cryostat
- 5.3.2.1. Global Anatomic Pathology Market, by Microtomes & Cryostat, by Region, 2018 - 2030 (USD Billion)
- 5.3.3. Tissue Processors
- 5.3.3.1. Global Anatomic Pathology Market, by Tissue Processors, by Region, 2018 - 2030 (USD Billion)
- 5.3.4. Automatic Stainers
- 5.3.4.1. Global Anatomic Pathology Market, by Automatic Stainers, by Region, 2018 - 2030 (USD Billion)
- 5.3.5. Whole Slide Imaging (WSI) Scanners
- 5.3.5.1. Global Anatomic Pathology Market, by Whole Slide Imaging (WSI) Scanners, by Region, 2018 - 2030 (USD Billion)
- 5.3.6. Other Products
- 5.3.6.1. Global Anatomic Pathology Market, by Other Products, by Region, 2018 - 2030 (USD Billion)
- 5.4. Consumables
- 5.4.1. Global Anatomic Pathology Market, by Consumables, by Region, 2018 - 2030 (USD Billion)
- 5.4.2. Reagents & Antibodies
- 5.4.2.1. Global Anatomic Pathology Market, by Reagents & Antibodies, by Region, 2018 - 2030 (USD Billion)
- 5.4.3. Probes & Kits
- 5.4.3.1. Global Anatomic Pathology Market, by Probes & Kits, by Region, 2018 - 2030 (USD Billion)
- 5.4.4. Others
- 5.4.4.1. Global Anatomic Pathology Market, by Others, by Region, 2018 - 2030 (USD Billion)
- 5.5. Services
- 5.5.1. Global Anatomic Pathology Market, by Services, by Region, 2018 - 2030 (USD Billion)
6. Global Anatomic Pathology Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 6.3. Disease Diagnosis
- 6.3.1. Global Anatomic Pathology Market, by Disease Diagnosis, by Region, 2018 - 2030 (USD Billion)
- 6.4. Drug Discovery and Development
- 6.4.1. Global Anatomic Pathology Market, by Drug Discovery and Development, by Region, 2018 - 2030 (USD Billion)
- 6.5. Others
- 6.5.1. Global Anatomic Pathology Market, by Others, by Region, 2018 - 2030 (USD Billion)
7. Global Anatomic Pathology Market, by End-Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Global Anatomic Pathology Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
- 7.4. Research Laboratories
- 7.4.1. Global Anatomic Pathology Market, by Research Laboratories, by Region, 2018 - 2030 (USD Billion)
- 7.5. Diagnostic Laboratories
- 7.5.1. Global Anatomic Pathology Market, by Diagnostic Laboratories, by Region, 2018 - 2030 (USD Billion)
- 7.6. Others
- 7.6.1. Global Anatomic Pathology Market, by Others, by Region, 2018 - 2030 (USD Billion)
8. Global Anatomic Pathology Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Anatomic Pathology Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 8.3. Anatomic Pathology Market - North America
- 8.3.1. North America: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.3.2. North America: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.3.3. North America: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.3.4. Anatomic Pathology Market - U.S.
- 8.3.4.1. U.S.: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.3.4.2. U.S.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.3.4.3. U.S.: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.3.5. Anatomic Pathology Market - Canada
- 8.3.5.1. Canada: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.3.5.2. Canada.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.3.5.3. Canada: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.4. Anatomic Pathology Market - Europe
- 8.4.1. Europe: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.2. Europe.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.3. Europe: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.4. Anatomic Pathology Market - UK
- 8.4.4.1. UK: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.4.2. UK.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.4.3. UK: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.5. Anatomic Pathology Market - France
- 8.4.5.1. France: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.5.2. France.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.5.3. France: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.6. Anatomic Pathology Market - Germany
- 8.4.6.1. Germany: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.6.2. Germany.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.6.3. Germany: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.7. Anatomic Pathology Market - Italy
- 8.4.7.1. Italy: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.7.2. Italy.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.7.3. Italy: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.8. Anatomic Pathology Market - Spain
- 8.4.8.1. Spain: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.8.2. Spain.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.8.3. Spain: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.9. Anatomic Pathology Market - Netherlands
- 8.4.9.1. Netherlands: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.9.2. Netherlands.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.9.3. Netherlands: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.10. Anatomic Pathology Market - Austria
- 8.4.10.1. Austria: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.10.2. Austria.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.10.3. Austria: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.5. Anatomic Pathology Market - Asia Pacific
- 8.5.1. Asia Pacific: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.2. Asia Pacific.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.5.3. Asia Pacific: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.4. Anatomic Pathology Market - China
- 8.5.4.1. China: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.4.2. China.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.5.4.3. China: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.5. Anatomic Pathology Market - India
- 8.5.5.1. India: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.5.2. India.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.5.5.3. India: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.6. Anatomic Pathology Market - Malaysia
- 8.5.6.1. Malaysia: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.6.2. Malaysia.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.5.6.3. Malaysia: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.7. Anatomic Pathology Market - Japan
- 8.5.7.1. Japan: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.7.2. Japan.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.5.7.3. Japan: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.8. Anatomic Pathology Market - Indonesia
- 8.5.8.1. Indonesia: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.8.2. Indonesia.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.5.8.3. Indonesia: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.9. Anatomic Pathology Market - South Korea
- 8.5.9.1. South Korea: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.9.2. South Korea.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.5.9.3. South Korea: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.6. Anatomic Pathology Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.2. Middle East & Africa.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.6.3. Middle East & Africa: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.6.4. Anatomic Pathology Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.6.4.3. Saudi Arabia: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.6.5. Anatomic Pathology Market - UAE
- 8.6.5.1. UAE: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.5.2. UAE.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.6.5.3. UAE: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.6.6. Anatomic Pathology Market - Israel
- 8.6.6.1. Israel: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.6.2. Israel.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.6.6.3. Israel: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.6.7. Anatomic Pathology Market - South Africa
- 8.6.7.1. South Africa: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.7.2. South Africa.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.6.7.3. South Africa: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.7. Anatomic Pathology Market - Latin America
- 8.7.1. Latin America: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.7.2. Latin America.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.7.3. Latin America: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.7.4. Anatomic Pathology Market - Mexico
- 8.7.4.1. Mexico: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.7.4.2. Mexico.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.7.4.3. Mexico: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.7.5. Anatomic Pathology Market - Brazil
- 8.7.5.1. Brazil: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.7.5.2. Brazil.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.7.5.3. Brazil: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
- 8.7.6. Anatomic Pathology Market - Argentina
- 8.7.6.1. Argentina: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
- 8.7.6.2. Argentina.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.7.6.3. Argentina: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abcam plc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Agilent Technologies
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Amos Scientific Pty Ltd.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Beckton
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Bio SB
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. BioGenex
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Bright Instruments
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Cardinal Health
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Cell Signaling Technology, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. CellPath Ltd.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Danaher Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Diapath S.p.A
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Dickson and Company
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. F. Hoffmann-La Roche AG
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Histo-Line Laboratories
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. Hologic, Inc.
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
- 10.17. Jinhua Yidi Medical Equipment Co., Ltd.
- 10.17.1. Company Overview
- 10.17.2. Financial Performance
- 10.17.3. Product Benchmarking
- 10.17.4. Recent Development
- 10.18. Laboratory Corporation of America Holdings
- 10.18.1. Company Overview
- 10.18.2. Financial Performance
- 10.18.3. Product Benchmarking
- 10.18.4. Recent Development
- 10.19. Lupetec
- 10.19.1. Company Overview
- 10.19.2. Financial Performance
- 10.19.3. Product Benchmarking
- 10.19.4. Recent Development
- 10.20. Medimeas
- 10.20.1. Company Overview
- 10.20.2. Financial Performance
- 10.20.3. Product Benchmarking
- 10.20.4. Recent Development
- 10.21. MEDITE Medical GmbH
- 10.21.1. Company Overview
- 10.21.2. Financial Performance
- 10.21.3. Product Benchmarking
- 10.21.4. Recent Development
- 10.22. Merck KGaA
- 10.22.1. Company Overview
- 10.22.2. Financial Performance
- 10.22.3. Product Benchmarking
- 10.22.4. Recent Development
- 10.23. MICROS AUSTRIA
- 10.23.1. Company Overview
- 10.23.2. Financial Performance
- 10.23.3. Product Benchmarking
- 10.23.4. Recent Development
- 10.24. Milestone Medical
- 10.24.1. Company Overview
- 10.24.2. Financial Performance
- 10.24.3. Product Benchmarking
- 10.24.4. Recent Development
- 10.25. NeoGenomics Laboratories, Inc
- 10.25.1. Company Overview
- 10.25.2. Financial Performance
- 10.25.3. Product Benchmarking
- 10.25.4. Recent Development
- 10.26. PHC Holdings Corporation
- 10.26.1. Company Overview
- 10.26.2. Financial Performance
- 10.26.3. Product Benchmarking
- 10.26.4. Recent Development
- 10.27. Quest Diagnostics Incorporated
- 10.27.1. Company Overview
- 10.27.2. Financial Performance
- 10.27.3. Product Benchmarking
- 10.27.4. Recent Development
- 10.28. R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED
- 10.28.1. Company Overview
- 10.28.2. Financial Performance
- 10.28.3. Product Benchmarking
- 10.28.4. Recent Development
- 10.29. Sakura Finetek
- 10.29.1. Company Overview
- 10.29.2. Financial Performance
- 10.29.3. Product Benchmarking
- 10.29.4. Recent Development
- 10.30. SLEE medical GmbH
- 10.30.1. Company Overview
- 10.30.2. Financial Performance
- 10.30.3. Product Benchmarking
- 10.30.4. Recent Development